Wave Life Sciences (WVE) Non-Current Deffered Revenue (2016 - 2025)
Historic Non-Current Deffered Revenue for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $11.7 million.
- Wave Life Sciences' Non-Current Deffered Revenue fell 3682.53% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year decrease of 3682.53%. This contributed to the annual value of $6.1 million for FY2024, which is 6090.64% down from last year.
- Per Wave Life Sciences' latest filing, its Non-Current Deffered Revenue stood at $11.7 million for Q3 2025, which was down 3682.53% from $4.2 million recorded in Q2 2025.
- Over the past 5 years, Wave Life Sciences' Non-Current Deffered Revenue peaked at $130.8 million during Q1 2023, and registered a low of $4.2 million during Q2 2025.
- For the 5-year period, Wave Life Sciences' Non-Current Deffered Revenue averaged around $59.8 million, with its median value being $76.6 million (2022).
- As far as peak fluctuations go, Wave Life Sciences' Non-Current Deffered Revenue surged by 9117.04% in 2021, and later crashed by 9083.41% in 2024.
- Over the past 5 years, Wave Life Sciences' Non-Current Deffered Revenue (Quarter) stood at $77.5 million in 2021, then increased by 2.96% to $79.8 million in 2022, then plummeted by 80.44% to $15.6 million in 2023, then plummeted by 60.91% to $6.1 million in 2024, then surged by 91.52% to $11.7 million in 2025.
- Its Non-Current Deffered Revenue stands at $11.7 million for Q3 2025, versus $4.2 million for Q2 2025 and $5.6 million for Q1 2025.